会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 14. 发明授权
    • Platelet aggregation inhibitory agents
    • 血小板聚集抑制剂
    • US5219867A
    • 1993-06-15
    • US927684
    • 1992-08-10
    • Ramachander GollamudiZixia Feng
    • Ramachander GollamudiZixia Feng
    • C07D211/60
    • C07D211/60
    • The present invention relates to substantially pure stereoisomers of a compound of the formula: ##STR1## wherein n.sub.1 and n.sub.2 are the same or different and are 1 or 2; X is alkyl (C.sub.1 -C.sub.10), aryl (C.sub.6 -C.sub.10) or aralkyl (C.sub.7 -C.sub.12); and wherein R, R.sub.1, R.sub.2 and R.sub.3 are the same or different and are chosen from H, alkyl (C.sub.1 -C.sub.10), aryl (C.sub.6 -C.sub.10), aralkyl (C.sub.7 -C.sub.12), or a heterocyclic group, and addition salts thereof with pharmaceutically acceptable acids. The invention also relates to a method for the inhibition of blood platelet aggregation in a blood supply comprising administering to said blood supply a blood platelet aggregation inhibiting amount of the compounds of the present invention.
    • 本发明涉及下式化合物的基本上纯的立体异构体:其中n1和n2相同或不同,为1或2; X是烷基(C1-C10),芳基(C6-C10)或芳烷基(C7-C12); 并且其中R,R 1,R 2和R 3相同或不同并且选自H,烷基(C 1 -C 10),芳基(C 6 -C 10),芳烷基(C 7 -C 12)或杂环基, 与药学上可接受的酸。 本发明还涉及抑制血液供应中的血小板聚集的方法,包括对所述血液供给血小板聚集抑制量的本发明化合物。